Stratifying the prognostic role of stromal infiltration of cytotoxic T cells by KRAS or BRAF mutation status in both the study cohort and the NSHDS validation cohort, revealed a prognostic role of cytotoxic T cells independent of KRAS and BRAF mutation in CRC (Fig. 2). Here, KRAS is linked to colorectal carcinoma.